Literature DB >> 33750455

Prolonged activation of cytomegalovirus early gene e1-promoter exclusively in neurons during infection of the developing cerebrum.

Isao Kosugi1, Yoshifumi Arai2, Satoshi Baba3, Hideya Kawasaki4, Toshihide Iwashita5, Yoshihiro Tsutsui5,6.   

Abstract

The brain is the major target of congenital cytomegalovirus (CMV) infection. It is possible that neuron disorder in the developing brain is a critical factor in the development of neuropsychiatric diseases in later life. Previous studies using mouse model of murine CMV (MCMV) infection demonstrated that the viral early antigen (E1 as a product of e1 gene) persists in the postnatal neurons of the hippocampus (HP) and cerebral cortex (CX) after the disappearance of lytic infection from non-neuronal cells in the periventricular (PV) region. Furthermore, neuron-specific activation of the MCMV-e1-promoter (e1-pro) was found in the cerebrum of transgenic mice carrying the e1-pro-lacZ reporter construct. In this study, in order to elucidate the mechanisms of e1-pro activation in cerebral neurons during actual MCMV infection, we have generated the recombinant MCMV (rMCMV) carrying long e1-pro1373- or short e1-pro448-EGFP reporter constructs. The length of the former, 1373 nucleotides (nt), is similar to that of transgenic mice. rMCMVs and wild type MCMV did not significantly differed in terms of viral replication or E1 expression. rMCMV-infected mouse embryonic fibroblasts showed lytic infection and activation of both promoters, while virus-infected cerebral neurons in primary neuronal cultures demonstrated the non-lytic and persistent infection as well as the activation of e1-pro-1373, but not -448. In the rMCMV-infected postnatal cerebrum, lytic infection and the activation of both promoters were found in non-neuronal cells of the PV region until postnatal 8 days (P8), but these disappeared at P12, while the activation of e1-pro-1373, but not -448 appeared in HP and CX neurons at P8 and were prolonged exclusively in these neurons at P12, with preservation of the neuronal morphology. Therefore, e1-pro-448 is sufficient to activate E1 expression in non-neuronal cells, however, the upstream sequence from nt -449 to -1373 in e1-pro-1373 is supposed to work as an enhancer necessary for the neuron-specific activation of e1-pro, particularly around the second postnatal week. This unique activation of e1-pro in developing cerebral neurons may be an important factor in the neurodevelopmental disorders induced by congenital CMV infection.

Entities:  

Keywords:  Cerebral neuron; Congenital infection; Cytomegalovirus; Neurodevelopmental disorder; Persistent infection; e1-promoter

Year:  2021        PMID: 33750455      PMCID: PMC7941713          DOI: 10.1186/s40478-021-01139-0

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


  53 in total

Review 1.  Inhibition of programmed cell death by cytomegaloviruses.

Authors:  Wolfram Brune
Journal:  Virus Res       Date:  2010-10-20       Impact factor: 3.303

2.  Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins.

Authors:  B Bühler; G M Keil; F Weiland; U H Koszinowski
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In Utero.

Authors:  Benjamin J S Al-Haddad; Bo Jacobsson; Shilpi Chabra; Dominika Modzelewska; Erin M Olson; Raphael Bernier; Daniel A Enquobahrie; Henrik Hagberg; Svante Östling; Lakshmi Rajagopal; Kristina M Adams Waldorf; Verena Sengpiel
Journal:  JAMA Psychiatry       Date:  2019-06-01       Impact factor: 21.596

4.  The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).

Authors:  J H Ahn; W J Jang; G S Hayward
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter.

Authors:  H Arlt; D Lang; S Gebert; T Stamminger
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Neuron-specific activation of murine cytomegalovirus early gene e1 promoter in transgenic mice.

Authors:  Yoshifumi Arai; Mizuho Ishiwata; Satoshi Baba; Hideya Kawasaki; Isao Kosugi; Ren-Yong Li; Takashi Tsuchida; Katsutoshi Miura; Yoshihiro Tsutsui
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques.

Authors:  W L William Chang; Alice F Tarantal; Shan Shan Zhou; Alexander D Borowsky; Peter A Barry
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 8.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

9.  Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice.

Authors:  R D Cardin; G B Abenes; C A Stoddart; E S Mocarski
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

10.  Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci.

Authors:  A D Børglum; D Demontis; J Grove; J Pallesen; M V Hollegaard; C B Pedersen; A Hedemand; M Mattheisen; A Uitterlinden; M Nyegaard; T Ørntoft; C Wiuf; M Didriksen; M Nordentoft; M M Nöthen; M Rietschel; R A Ophoff; S Cichon; R H Yolken; D M Hougaard; P B Mortensen; O Mors
Journal:  Mol Psychiatry       Date:  2013-01-29       Impact factor: 15.992

View more
  1 in total

Review 1.  Murine Models of Central Nervous System Disease following Congenital Human Cytomegalovirus Infections.

Authors:  Jerome Moulden; Cathy Yea Won Sung; Ilija Brizic; Stipan Jonjic; William Britt
Journal:  Pathogens       Date:  2021-08-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.